Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes

Molecular Carcinogenesis

Volumn 17, Issue 4, 1996, Pages 207-216

  Maldve, Regina E ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cyclooxygenase; keratinocytes; non TPA type tumor promoters; phorbol ester; tumor promotion

Indexed keywords

MESSENGER RNA; PHORBOL ESTER; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE C; TUMOR PROMOTER;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TUMOR PROMOTION;

ANIMALS; CARCINOGENS; CELLS, CULTURED; DOWN-REGULATION; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; ISOENZYMES; KERATINOCYTES; MICE; MICE, INBRED SENCAR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; MURINAE; TRIXIS;

EID: 0030464398     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199612)17:4<207::AID-MC4>3.0.CO;2-A     Document Type: Article

References (63)

1. DeWitt DL. Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1093:121-134, 1991.
2. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: Structure and catalysis. Biochim Biophys Acta 1083:1-17, 1991.
3. Smith WL, Marnett LJ, DeWitt DL. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49:153-179, 1991.
4. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev 13:241-256, 1994.
5. Boutwell RK. Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 4:207-250, 1964.
6. Fürstenberger G, Berry DL, Sorg B, Marks F. Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci USA 78:7722-7726, 1981.
7. Slaga TJ, Fischer SM, Nelson K, Gleason GL. Studies on the mechanism of skin tumor promotion: Evidence for several stages in promotion. Proc Natl Acad Sci USA 77:3659-3663, 1980.
8. Raick AN. Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoylphorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. Cancer Res 33:269-286, 1973.
9. Slaga TJ, Fischer SM, Weeks CE, Klein-Szanto AJP. Multistage carcinogenesis in mouse skin. In: Bernstein A, Seiji M (eds), Biochemistry of Normal and Abnormal Differentiation, S. Karger, Inc., Basel 1980, pp. 193-218.
10. Nishizuka Y. Studies and prospectives of protein kinase C. Science 233:305-311, 1986.
11. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63-128, 1992.
12. DiGiovanni J, Decina PC, Prichett WP, Cantor J, Aalfs KK, Coombs MM. Mechanisms of mouse skin tumor promotion by chrysarobin. Cancer Res 45:2584-2589, 1985.
13. Klein-Szanto AJP, Slaga TJ. Effects of peroxides on rodent skin: Epidermal hyperplasia and tumor promotion. J Invest Dermatol 79:30-34, 1982.
14. Suganuma M, Fujiki H, Sugurui H, et al. Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771, 1988.
15. Suganuma M, Suttajit M, Suguri H, Ojika M, Yamada K, Fujiki H. Specific binding of okadaic acid, a new tumor promoter in mouse skin FEBS Lett 250:615-618, 1989.
16. Imamoto A, Beltrán LM, DiGiovanni J. Evidence for autocrine/ paracrine growth stimulation by transforming growth factor-α during the process of skin tumor promotion. Mol Carcinog 4:52-60, 1991.
17. Naito M, Naito Y, DiGiovanni J. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. Carcinogenesis 8:1807-1815, 1987.
18. Slaga TJ, Fischer SM, Viaje A, et al. Inhibition of tumor promotion of anti-inflammatory agents: An approach to the biochemical mechanisms of promotion. In: Slaga TJ, Sirvak A, Boutwell RK (eds), Mechanisms of Tumor Promotion and Cocarcinogenesis, Carcinogenesis, Vol. 2. Raven Press, New York, 1978, pp. 173-195.
19. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 268:6610-5614, 1993.
20. Fischer SM, Gleason GL, Bohrman JL, Slaga TJ. Prostaglandin enhancement of skin tumor initiation and promotion. Adv Prostaglandin Thromboxane Res 6:517-522, 1980.
21. Fischer SM, Fürstenberger G, Marks F, Slaga TJ. Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: A comparison between Sencar and NMRI mice. Cancer Res 47:3174-3179, 1987.
22. Fürstenberger G, Richter H, Fusenig NE, Marks F. Arachidonic acid and prostaglandin E release and enhanced cell proliferation induced by the phorbol ester TPA in murine epidermal cell line. Cancer Lett 11:191-198, 1980.
23. Verma AK, Ashendel CL, Boutwell RK. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 40:308-315, 1980.
24. Young MR, Knies SJ. Prostaglandin E production by Lewis lung carcinoma: Mechanisms for tumor establishment in vivo. J Natl Cancer Inst 72:919-922, 1984.
25. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88:2692-2696, 1991.
26. Fischer SM, Patrick KE, Lee ML, Cameron GS. 4β- and 4α-12-O-tetradcanoylphorbol-13-acetate elicit arachidonic release from epidermal cells through different mechanisms. Cancer Res 51:850-856, 1991.
27. Müller-Decker K, Scholz K, Marks F, Fürstenberger G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 12:31-41, 1995.
28. Goppelt-Struebe M. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukot Essent Fatty Acids 52:213-222, 1995.
29. 2 release from primary cultures of mouse epidermal cells. Eur J Pharmacol 182:19-28, 1990.
30. 2 release from primary cultured mouse epidermal cells. Jpn J Pharmacol 60:9-17, 1992.
31. Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys 304:226-234, 1993.
32. Yuspa SH, Harris CC. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res 86:95-105, 1974.
33. Balmain A, Krumlauf R, Vass JK, Birnie GD. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 10:4259-4279, 1982.
34. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting esters. J Biol Chem 257:7847-7851, 1982.
35. Fischer SM, Jasheway DW, Klann RC, et al. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C. Cancer Res 49:6693-6699, 1989.
36. Solanki V, Slaga TJ. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from SENCAR mice. Proc Natl Acad Sci USA 78:2549-2553, 1981.
37. 2 release by epidermal growth factor and a tumor promoter anthralin from primary cultures of mouse epidermal cells. Jpn J Pharmacol 57:361-366, 1991.
38. Bialojan C, Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Biochem J 256:283-290, 1988.
39. King, Jr LE, Carpenter GC. Epidermal growth factor. In: Goldsmith LA (ed), Biochemistry and Physiology of the Skin. Oxford University Press, New York, 1983, pp. 269-281.
40. Muller R, Bravo R, Burckhardt J, Curran T. Induction of c-fos and protein by growth factors precedes activation of c-myc. Nature 312:716-720, 1984.
41. Rose SP, Stahn R, Passovoy DS, Herschman HR. Epidermal growth factor enhancement of skin tumor induction in mice. Experientia 32:913-915, 1976.
42. Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J. Altered expression of the epidermal growth factor receptor and transforming growth factor-α during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28, 1994.
43. Chepenik KP, Diaz A, Jimenez SA. Epidermal growth factor coordinately regulates the expression of prostaglandin G/H synthase and cytosolic phospholipase A2 genes in embryonic mouse cells. J Biol Chem 269:21786-21792, 1994.
44. Kruszewski FH, Naito M, Naito Y, DiGiovanni J. Histologic alteration produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: Relationship to skin tumor promoting activity. J Invest Dermatol 92:64-71, 1989.
45. Fürstenberger G, Mark F. Prostaglandins, epidermal hyperplasia and skin tumor promotion. In: Fischer SM, Slaga TJ (eds), Arachidonic Acid Metabolism and Tumor Promotion. Martinus Nijhoff Publishing, Boston, 1985, pp. 49-72.
46. Martinmaa J, Vanhala L, Mustakallio KK. Free radical intermediates produced by the autooxidation of 1,8-dihydroxy-9-anthrone (dithranol) in pyridine. Experientia 43:872-873, 1978.
47. Battalora MS, Kruszewski FH, DiGiovanni J. Inhibition of chrysarobin skin tumor promotion in SENCAR mice by antioxidants. Carcinogenesis 14:2507-2512, 1993.
48. Vilusksela M. Characteristics and modulation of dithranol (anthralin)-induced skin irritation in the mouse ear model. Arch Dermatol Res 283:262-268, 1991.
49. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95:1669-1675, 1995.
50. Slaga TJ, Klein-Szanto AJP, Triplett LL, Yotti LP, Trosko KE. Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound. Science 213:1023-1025, 1981.
51. Fischer SM, Slaga TJ. Arachidonic Acid Metabolism and Tumor Promotion. Martinus Nijhoff, Boston, 1985.
52. O'Brien TG, Simsiman RC, Boutwell RK. Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumorpromoting agents. Cancer Res 35:1662-1670, 1975.
53. Yuspa SH, Lichti U, Ben T, et al. Phorbol-ester tumor promoters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures. Nature 262:402-404, 1976.
54. Fujiki H, Suganuma M. Tumor promotion by inhibitors of protein phosphatases 1 and 2A: The okadaic acid class of compounds. Adv Cancer Res 61:143-194, 1993.
55. Holladay K, Fujiki H, Bowden GT. Okadaic acid induces the expression of both early and secondary response genes in mouse keratinocytes. Mol Carcinog 5:16-24, 1992.
56. Scholz K, Fürstenberger G, Müller-Decker K, Marks F. Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J 309:263-269, 1995
57. Kiguchi K, Beltran LM, You J, Rho O, DiGiovanni J. Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol Carcinog 12:225-235, 1995.
58. Derynck R. Transforming growth factor α: Structure and biological activities. J Cell Biochem 32:293-304, 1988.
59. Reiss M, Stash EB, Vellucci VF, Zhou Z. Activation of the autocrine transforming growth factor α in human squamous carcinoma cells. Cancer Res 51:6254-6262, 1991.
60. Merlino GT, Ishii S, Whang-Peng J, et al. Structure and localization of gene encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 5:1722-1734, 1985.
61. Hendler FJK, Ozanne BW. Human squamous cell lung cancer express increased epidermal growth factor receptors. J Clin Invest 74:647-651, 1984.
62. Derynck R, Goedell DV, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712, 1987.
63. DuBois RN, Awad J, Morrow J, Roberts U II, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transformed growth factor-α and phorbol ester. J Clin Invest 93:493-498, 1994.